Epigenetic Regulation of Adipogenesis
$262,288ZIAFY2009DKNIH
National Institute Of Diabetes And Digestive And Kidney Diseases
Investigators
Linked publications & trials
Paper 38063851Paper 38012390Paper 36378541Paper 35926054Paper 33888555Paper 33712604Paper 32601106Paper 32544095Paper 32541010Paper 32446320Paper 32365172Paper 31968253Paper 31296899Paper 30936246Paper 30335158Paper 29911994Paper 29728617Paper 29263365Paper 29077876Paper 28669924Paper 28398509Paper 27777311Paper 27777310Paper 27443740Paper 26932671Paper 26366712Paper 26366710Paper 25071153Paper 24904744Paper 24743992Paper 24633704Paper 24368734Paper 23987512Paper 23727112Paper 23503590Paper 23178591Paper 22240386Paper 22068036Paper 20368440Paper 20080985Paper 19583951Paper 19124460Paper 18039840Paper 17500065
Abstract
Specific Aim 1: examine the change of histone modifications on PPARgamma promoter in the early phase of adipogenesis. By ChIP assays, we have observed robust change of multiple histone acetylation and methylation on PPARgamma promoter in the early phase of adipogenesis. Specific Aim 2: investigate the functional significance of the histone modification change on PPARgamma promoter by depleting the responsible enzymes. Specific Aim 3: investigate the roles of other epigenetic mechanisms, in particular chromatin remodeling and non-coding RNAs, in regulation of PPARgamma expression and adipogenesis.
View original record on NIH RePORTER →